Duality Advisers, LP Crispr Therapeutics Ag Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$43.23 - $73.83 $1.26 Million - $2.15 Million	29,132 Added 160.49%	47,284 $2.87 Million
Q1 2022 May 09, 2022	BUY	$53.19 - $79.24 $253,556 - $377,737	4,767 Added 35.61%	18,152 $1.14 Million
Q4 2021 Feb 02, 2022	BUY	$70.09 - $111.29 $309,517 - $491,456	4,416 Added 49.24%	13,385 $1.01 Million
Q3 2021 Nov 08, 2021	BUY	$110.2 - $156.64 $988,383 - $1.4 Million	8,969 New	8,969 $1 Million
Q2 2021 Aug 09, 2021	SELL	$100.84 - $161.89 $433,914 - $696,612	-4,303 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $476,428 - $903,802	4,303 New	4,303 $524,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.